A Rationale for the Use of Clotted Vertebral Bone Marrow to Aid Tissue Regeneration Following Spinal Surgery

Vertebral body bone marrow aspirate (V-BMA), easily accessible simultaneously with the preparation of the site for pedicle screw insertion during spinal procedures, is becoming an increasingly used cell therapy approach in spinal surgery. However, the main drawbacks for V-BMA use are the lack of a standardized procedure and of a structural texture with the possibility of diffusion away from the implant site. The aim of this study was to evaluate, characterize and compare the biological characteristics of MSCs from clotted V-BMA and MSCs from whole and concentrate V-BMAs. MSCs from clotted V-BMA showed the highest cell viability and growth factors expression (TGF-β, VEGF-A, FGF2), the greatest colony forming unit (CFU) potency, cellular homogeneity, ability to differentiate towards the osteogenic (COL1AI, TNFRSF11B, BGLAP) and chondrogenic phenotype (SOX9) and the lowest ability to differentiate toward the adipogenic lineage (ADIPOQ) in comparison to all the other culture conditions. Additionally, results revealed that MSCs, differently isolated, expressed different level of HOX and TALE signatures and that PBX1 and MEIS3 were down-regulated in MSCs from clotted V-BMA in comparison to concentrated one. The study demonstrated for the first time that the cellular source inside the clotted V-BMA showed the best biological properties, representing an alternative and advanced cell therapy approach for patients undergoing spinal surgery.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Scientific reports - 10(2020), 1 vom: 05. März, Seite 4115

Sprache:

Englisch

Beteiligte Personen:

Salamanna, F [VerfasserIn]
Contartese, D [VerfasserIn]
Giavaresi, G [VerfasserIn]
Sicuro, L [VerfasserIn]
Barbanti Brodano, G [VerfasserIn]
Gasbarrini, A [VerfasserIn]
Fini, M [VerfasserIn]

Links:

Volltext

Themen:

Antigens, Surface
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 26.11.2020

Date Revised 05.03.2021

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-020-60934-2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM307281884